Estimating long-term effects of treatment from placebo-controlled trials with an extension period, using virtual twins

被引:13
作者
Vittinghoff, Eric [1 ]
McCulloch, Charles E. [1 ]
Woo, Claudine [2 ]
Cummings, Steven R. [2 ]
机构
[1] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94107 USA
[2] Calif Pacific Med Ctr, San Francisco, CA 94107 USA
关键词
placebo-controlled trials; G-computation; long-term effects; missing at random; FRACTURE INTERVENTION TRIAL; OPEN-LABEL EXTENSION; FOLLOW-UP; RANDOMIZED-TRIAL; VERTEBRAL FRACTURES; ALENDRONATE; WOMEN; DISEASE; RISK; OSTEOPOROSIS;
D O I
10.1002/sim.3870
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The best information about the benefits of long-term treatment is obtained from a long-term placebo-controlled trial. However, once efficacy has been demonstrated in relatively brief trials, it may not be possible to conduct long-term placebo-controlled trials, for ethical or practical reasons. This paper presents a method for estimating long-term effects of a treatment from a placebo-controlled trial in which some participants originally randomized to active-treatment volunteer to continue on treatment during an extension study, but follow-up of participants originally assigned to placebo ends with the trial, or they are crossed over to active treatment during the extension. We propose using data from the trial to project the outcomes for a 'virtual twin' for each active-treatment volunteer under the counterfactual placebo condition, and using bootstrap methods for inference. The proposed method is validated using simulation, and applied to data rom the Fracture Intervention Trial and its extension, FLEX. Copyright (C) 2010 John Wiley & Sons, Ltd.
引用
收藏
页码:1127 / 1136
页数:10
相关论文
共 23 条
[1]   Effects of continuing or stopping alendronate after 5 years of treatment - The Fracture Intervention Trial long-term extension (FLEX): A randomized trial [J].
Black, Dennis M. ;
Schwartz, Ann V. ;
Ensrud, Kristine E. ;
Cauley, Jane A. ;
Levis, Silvina ;
Quandt, Sara A. ;
Satterfield, Suzanne ;
Wallace, Robert B. ;
Bauer, Douglas C. ;
Palermo, Lisa ;
Wehren, Lois E. ;
Lombardi, Antonio ;
Santora, Arthur C. ;
Cummings, Steven R. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (24) :2927-2938
[2]  
BLACK DM, 1993, OSTEOPOROSIS INT, V3, pS29
[3]   Fracture risk reduction with alendronate in women with osteoporosis: The Fracture Intervention Trial [J].
Black, DM ;
Thompson, DE ;
Bauer, DC ;
Ensrud, K ;
Musliner, T ;
Hochberg, MC ;
Nevitt, MC ;
Suryawanshi, S ;
Cummings, SR .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (11) :4118-4124
[4]   Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures [J].
Black, DM ;
Cummings, SR ;
Karpf, DB ;
Cauley, JA ;
Thompson, DE ;
Nevitt, MC ;
Bauer, DC ;
Genant, HK ;
Haskell, WL ;
Marcus, R ;
Ott, SM ;
Torner, JC ;
Quandt, SA ;
Reiss, TF ;
Ensrud, KE .
LANCET, 1996, 348 (9041) :1535-1541
[5]   Ten years' experience with alendronate for osteoporosis in postmenopausal women [J].
Bone, HG ;
Hosking, D ;
Devogelaer, J ;
Tucci, JR ;
Emkey, RD ;
Tonino, RP ;
Rodriguez-Portales, JA ;
Downs, RW ;
Gupta, J ;
Santora, AC ;
Liberman, UA .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (12) :1189-1199
[6]   Long-term effects of ramipril on cardiovascular events and on diabetes - Results of the HOPE study extension [J].
Bosch, J ;
Lonn, E ;
Pogue, J ;
Arnold, JMO ;
Dagenais, GR ;
Yusuf, S .
CIRCULATION, 2005, 112 (09) :1339-1346
[7]   Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures - Results from the fracture intervention trial [J].
Cummings, SR ;
Black, DM ;
Thompson, DE ;
Applegate, WB ;
Barrett-Connor, E ;
Musliner, TA ;
Palermo, L ;
Prineas, R ;
Rubin, SM ;
Scott, JC ;
Vogt, T ;
Wallace, R ;
Yates, AJ ;
LaCroix, AZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (24) :2077-2082
[8]   Long-term results of tamoxifen prophylaxis for breast cancer-96-month follow-up of the randomized IBIS-I trial [J].
Cuzick, Jack ;
Forbes, John F. ;
Sestak, Ivana ;
Cawthorn, Simon ;
Hamed, Hisham ;
Holli, Kaija ;
Howell, Anthony .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (04) :272-282
[9]   Randomized trial of effect of alendronate continuation versus discontinuation in women with low BMD: Results from the Fracture Intervention Trial long-term extension [J].
Ensrud, KE ;
Barrett-Connor, EL ;
Schwartz, A ;
Santora, AC ;
Bauer, DC ;
Suryawanshi, S ;
Feldstein, A ;
Haskell, WL ;
Hochberg, MC ;
Torner, JC ;
Lombardi, A ;
Black, DM .
JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 (08) :1259-1269
[10]   An open-label extension trial of galantamine in patients with probable vascular dementia and mixed dementia [J].
Erkinjuntti, T ;
Kurz, A ;
Small, GW ;
Bullock, R ;
Lilienfeld, S ;
Damaraju, CV .
CLINICAL THERAPEUTICS, 2003, 25 (06) :1765-1782